AUROPHARMA.BOAUROPHARMA.BO
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$64.36B
↑ 44% above average
Average (9y)
$44.83B
Historical baseline
Range
High:$64.36B
Low:$32.16B
CAGR
+8.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $64.36B | +11.7% |
| 2024 | $57.64B | +58.6% |
| 2023 | $36.34B | -15.7% |
| 2022 | $43.11B | -20.1% |
| 2021 | $53.95B | +12.3% |
| 2020 | $48.02B | +20.7% |
| 2019 | $39.80B | +4.3% |
| 2018 | $38.17B | +9.8% |
| 2017 | $34.76B | +8.1% |
| 2016 | $32.16B | - |